Evidence map›Paper›PMID 24409811›Full record

ReviewConnective tissue research2014

The applications of buckminsterfullerene C60 and derivatives in orthopaedic research.

Qihai Liu, Quanjun Cui, Xudong Joshua Li, Li Jin

Abstract readReview
In one paragraph

Review in Connective tissue research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Review
  3. Fullerene Gallium Phosphonate Shows Antimycobacterial Effect AgainstInternational journal of molecular sciences · 2025
    Article
  4. Review
  5. Review
  6. Effects of Aqueous Dispersions of CInternational journal of molecular sciences · 2021
    Article
  7. CNano-micro letters · 2019
    Article
  8. Article
  9. Review
  10. Nanoparticle fullerol alleviates radiculopathy via NLRP3 inflammasome and neuropeptides.Nanomedicine : nanotechnology, biology, and medicine · 2017
    Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Qihai LiuDepartment of Orthopedic Surgery, University of Virginia Health System , Charlottesville, VA , USA.
Quanjun Cui
Xudong Joshua Li
Li Jin
University of Virginia Health System · US

Funding

Systemic Application for Injury Site Specific Delivery via Neutrophils to Treat BR01AR064792 · NIAMS · UNIVERSITY OF VIRGINIA · PI LI, XUDONG J. · 2013 to 2018
$1.3M
Treatment of disc degeneration by nano-fullerenesR21AR057512 · NIAMS · UNIVERSITY OF VIRGINIA · PI LI, XUDONG J. · 2011 to 2012
$381k
NIAMS NIH HHS R01 AR064792NIAMS NIH HHS R21 AR057512NIAMS NIH HHS R21AR57512
6 · The paper itself

Abstract

Abstract Buckminsterfullerene C60 and derivatives have been extensively explored in biomedical research due to their unique structure and unparalleled physicochemical properties. C60 is characterized as a "free radical sponge" with an anti-oxidant efficacy several hundred-fold higher than conventional anti-oxidants. Also, the C60 core has a strong electron-attracting ability and numerous functional compounds with widely different properties can be added to this fullerene cage. This review focused on the applications of C60 and derivatives in orthopaedic research, such as the treatment of cartilage degeneration, bone destruction, intervertebral disc degeneration (IVDD), vertebral bone marrow disorder, radiculopathy, etc., as well as their toxicity in vitro and in vivo. We suggest that C60 and derivatives, especially the C60 cores coupled with functional groups presenting new biological and pharmacological activities, are advantageous in orthopaedic research and will be promising in clinical performance for musculoskeletal disorders treatment; however, the pharmacokinetics and toxicology of these agents as local/systemic administration need to be carefully determined.

Indexed as

Biomedical ResearchFree Radical ScavengersFullerenesAnimalsHumansIntervertebral Disc DegenerationOrthopedicsRadiculopathyFree Radical ScavengersFullerenes

Identifiers

PMID24409811
PMCPMC4124742
OpenAlexW1977246127

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.